Bank of Montreal
ARLZ

Bank of Montreal’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Bank of Montreal’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,000
Closed -$4K – 4454
2017
Q1 		$4K Buy
+2,000
New +$7.51K ﹤0.01% 3759

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Bank of Montreal's ARLZ Position: Q3 2018 in Review

Bank of Montreal sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 2,551 shares — an estimated $1K sold.

Bank of Montreal first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $142K in Q1 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Bank of Montreal reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Bank of Montreal sold 2,551 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $1K.
  • Bank of Montreal first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
  • Bank of Montreal's Aralez Pharmaceuticals Inc. position peaked at $142K in Q1 2016.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Bank of Montreal's 13F filing for Q3 2018, filed 12 Oct 2018.